Menu
- Home
+ - Publications
+
- Archives
+
- BCIQ
+
- Conferences
+
- eLearning
+
- Follow Us
Latest News
2:39 PM Jun 23, 2018
Latest batch of IPO filings: Rubius, Constellation, Replimune, Allakos
As a busy week for IPO pricings came to a close, several more companies filed for NASDAQ listings late...
4:44 PM Jun 22, 2018
Roche taps gRED’s Sabry as global head of partnering
A newly created global head of partnering role at Roche (SIX:ROG; OTCQX:RHHBY) is set to combine the...
4:16 PM Jun 22, 2018
FDA cracks down on missing postmarket trial
FDA determined the Perrigo Israel Pharmaceuticals Ltd. unit of Perrigo Co. plc (NYSE:PRGO; Tel Aviv:PRGO)...
4:01 PM Jun 22, 2018
Alzheimer's disease linked to herpesvirus
Researchers from the Icahn School of Medicine at Mount Sinai and colleagues found traces of mild strains...
3:55 PM Jun 22, 2018
Blocking LSD1 could activate cancer immune response via HERV
A Harvard Medical School team led by immunology and pathology professor Arlene Sharpe has shown inhibiting...
3:48 PM Jun 22, 2018
FDA lays out cancer PRO strategy
FDA staff set out the agency’s thinking and progress in developing a standard approach to assessing...
3:16 PM Jun 22, 2018
House passes sweeping opioid legislation
The House of Representatives passed a broad bipartisan measure Friday to combat the opioid crisis by a...
3:11 PM Jun 22, 2018
Crinetics proposes $86.3M IPO
Endocrine disease company Crinetics Pharmaceuticals Inc. (San Diego, Calif.) proposed to raise up to $86.3...
2:22 PM Jun 22, 2018
China accelerates drug review timelines for rare, life-threatening diseases
The China State Council set new policies to speed drug approvals, accelerate price cuts and market access...
7:56 PM Jun 21, 2018
First-day bump for Autolus after pricing $150M IPO
Autolus Therapeutics plc (NASDAQ:AUTL) climbed $8 (47%) to $25 its first day of trading Friday after it...
4:58 PM Jun 21, 2018
Sarepta says no to right to try for its DMD therapies
Following data from a small trial of a Duchenne muscular dystrophy gene therapy, Sarepta Therapeutics...
3:24 PM Jun 21, 2018
Low GABA transporter levels linked to alcohol dependence
In a Science paper published Wednesday, researchers at Linkoping University and colleagues showed a link...
3:07 PM Jun 21, 2018
FDA restricts Keytruda, Tecentriq monotherapy
FDA restricted the labels of Keytruda pembrolizumab and Tecentriq atezolizumab as monotherapy for...
3:07 PM Jun 21, 2018
Stakeholders release comprehensive opioid crisis action plan
Healthcare leaders should develop value-based and evidence-based models for integrated pain management and...
3:05 PM Jun 21, 2018
Nanobiotix’s NBTXR3 meets in Phase II/III for STS
Nanobiotix S.A. (Euronext:NANO) said NBTXR3 met the primary and secondary endpoints in the Phase II/III...
2:06 PM Jun 21, 2018
Beacon to develop right-to-try patient match platform
Beacon Pharmaceutical (New York, N.Y.) said it will launch a new platform to connect terminally ill...
2:05 PM Jun 21, 2018
UCSD launches bacteriophage treatment center
The University of California San Diego launched the Center for Innovative Phage Applications and...
1:52 PM Jun 21, 2018
Novo expands market cap on oral semaglutide data
Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) added DKK20.4 billion ($3.2 billion) in market cap in Copenhagen...
1:40 PM Jun 21, 2018
FDA releases draft guidance for antidepressant trials
FDA published draft guidance on developing drugs for major depressive disorder, which when finalized will...
11:57 AM Jun 21, 2018
Heron flying on Phase IIb pain data ahead of NDA
Heron Therapeutics Inc. (NASDAQ:HRTX) added $9.25 (30%) to $39.95 on Thursday after reporting that HTX-011...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.